John Dingell said...

Do you believe that the clinical trial standards laid out by FDA in the premarket approval process are rigorous enough to prove safety and effectiveness of class III devices?

Context

Dingell questions the adequacy of FDA's clinical trial standards for class III devices.

07/19/2011

https://congress.gov...